101 results
Page 5 of 6
8-K
EX-99.1
8nrg9
14 Nov 18
Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-10.9
i5tmxckpx01gy8nykeh
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-10.1
z6e5bn5h77r8mnxktvt
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-10.7
zx8f56r57 bwqnb
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-99.1
jfguypz
14 Aug 18
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
h83cehiu
25 May 18
Regulation FD Disclosure
8:30am
8-K
EX-99.1
3sfktx oi
21 May 18
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
8:15am
8-K
EX-99.1
od1ymem26y stfpq
3 May 18
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
8:00am
DEF 14A
56iu o0u72lyi63ab
30 Apr 18
Definitive proxy
7:02am
10-K
pa9kzg77z
1 Mar 18
Annual report
12:00am
8-K
EX-99.1
hgmhph4ecqom 03ha92t
14 Jul 17
Other Events
12:00am
10-Q
6007e
12 May 17
Quarterly report
12:00am
10-12G/A
5l5n8uis5
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
cvslxlm5ek2x
6 Mar 17
Registration of securities (amended)
12:00am
10-12G
eaybe96w7su zyy7r
12 Jan 17
Registration of securities
12:00am
10-12G/A
ii74cx6d8bgegcz
18 Feb 16
Registration of securities (amended)
12:00am